勃林格殷格翰品牌怎么样 申请店铺

更新时间:2024-10-28
勃林格殷格翰是哪个国家的品牌?「勃林格殷格翰」是 上海勃林格殷格翰药业有限公司 旗下著名品牌。该品牌发源于德国,在1885年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
勃林格殷格翰怎么样

兽药十大品牌,始于1885年德国,集人用药品/动物保健/生物制药为一体,致力于人类生物制药化学和动物健康产品研发,专注于生猪/家禽/宠物/牛的疫苗和药品领域


勃林格殷格翰 (Boehringer-Ingelheim)是一家专注人类生物制药化学和动物健康产品的医药公司。包括了处方药和保健消费品。 是世界上颇大的私有制药企业。勃林格殷格翰是一家高度研发驱动的公司,始终专注药品的研究、开发、生产及推广。

勃林格殷格翰的核心业务是人用药品,包括处方药、自主保健品和工业客户业务 (生物制药、药品生产和药用化学品)。勃林格殷格翰出产的药品一直被认为是治疗呼吸、心血管、中枢神经系统疾病及代谢紊乱、传染病的标杆。主要的研究领域包括免疫、肿瘤方面的适应症,目前多个具有治疗价值潜力的活性成分已经研发出来了。

勃林格殷格翰于1994年正式进入中国市场,目前在华投资总额超过2亿欧元,公司管理总部位于上海,业务遍布全国,拥有员工约3500名。勃林格殷格翰中国近年来发展迅速,包括人用药品、动物保健、生物制药3大业务板块并驾齐驱,协调发展,推动公司持续增长。


The top ten brand of veterinary medicine, started in 1885 in Germany, integrates human medicine / animal health care / biopharmaceutical as a whole, devotes to the research and development of human biopharmaceutical chemistry and animal health products, and focuses on the vaccine and drug field of pigs / Poultry / pets / cattle. Boehringer Ingelheim is a pharmaceutical company focusing on human biopharmaceutical chemistry and animal health products. It includes prescription drugs and health care consumer goods. It is a quite large private pharmaceutical enterprise in the world. Boehringer Ingelheim is a highly R & D driven company, which has always focused on the research, development, production and promotion of drugs. The core business of Boehringer Ingelheim is human drugs, including prescription drugs, independent health care products and industrial customer business (biopharmaceutical, pharmaceutical production and pharmaceutical chemicals). The drugs produced by Boehringer Ingelheim have been regarded as the benchmark for the treatment of respiratory, cardiovascular, central nervous system diseases, metabolic disorders and infectious diseases. The main research fields include immune and tumor indications. At present, a number of active ingredients with therapeutic potential have been developed. Boehringer Ingelheim officially entered the Chinese market in 1994. At present, the total investment in China is more than 200 million euros. The company's management headquarters is located in Shanghai, with businesses all over the country and about 3500 employees. In recent years, Boehringer Ingelheim has developed rapidly in China, including three business sectors of human drugs, animal health care and biopharmaceuticals, which are in line with each other, coordinated development and promoted the company's sustained growth.

本文链接: https://brand.waitui.com/a19fcecbe.html 联系电话:400-820-5970,800-820-5970

千城特选小程序码

7×24h 快讯

晋控煤业:前三季度归母净利润21.51亿元,同比降0.62%

36氪获悉,晋控煤业发布第三季度财报。财报显示,前三季度实现营业收入112.34亿元,同比下降0.19%;归属于上市公司股东的净利润21.51亿元,同比下降0.62%。第三季度实现营业收入38.55亿元,同比增长1.38%;归属于上市公司股东的净利润7.14亿元,同比下降8.25%。

19分钟前

财政部:1-9月国有企业营业总收入同比增长1.2%,利润总额同比下降2.3%

36氪获悉,财政部发布数据,1-9月,全国国有及国有控股企业营业总收入同比增长1.2%,利润总额同比下降2.3%。1-9月,国有企业营业总收入610580.1亿元,同比增长1.2%。1-9月,国有企业利润总额32487.0亿元,同比下降2.3%。1-9月,国有企业应交税费44136.7亿元,同比增长0.1%。9月末,国有企业资产负债率64.9%,上升0.1个百分点。

19分钟前

立昂微:第三季度营收8.18亿元,同比增长21.94%

36氪获悉,立昂微发布第三季度财报。财报显示,第三季度营收为8.18亿元,同比增长21.94%;净利润为1251.44万元,同比增长6.63%。

19分钟前

万兴科技万兴喵影焕新升级,推出十余项AI功能

36氪获悉,近日,万兴科技旗下视频创意软件万兴喵影桌面端发布全新版本万兴喵影2025。据了解,万兴喵影2025一次性新增上线超十项AI功能,助力视频创作增效提质,如AI翻译唇形驱动、智能马赛克等创作增效功能,以及AI超清、AI人声美化等视频提质功能。

19分钟前

立邦涂料宣布23亿美元收购复合材料供应商AOC

日本立邦涂料公司周一宣布,计划以23亿美元收购全球化学品配方制造商LSF11 A5 TopCo LLC,后者是是涂料、着色剂和复合树脂生产商AOC的母公司。根据周一提交给交易所的文件,这家日本涂料和化学品制造商表示,其目标是在2025财年上半年完成这笔交易,并将立邦涂料表示,此交易对当前日历年的任何财务影响都应该是微不足道的。(新浪财经)

19分钟前

本页详细列出关于勃林格殷格翰的品牌信息,含品牌所属公司介绍,勃林格殷格翰所处行业的品牌地位及优势。
咨询